Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis.
M C Torres GórrizJ Borrás CuarteroC G Pesántez MéndezC I Stein CoronadoE EnriquePublished in: Journal of investigational allergology & clinical immunology (2024)